About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Houston | 107 Studies

Clinical Trials Multiple SclerosisHouston

Multiple Sclerosis Clinical Trials in Houston

Find 107 clinical trials for multiple sclerosis near Houston, Texas. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 107 trials

CompletedStudy of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)The purpose of this study is to determine whether ozanimod is effective in the treatment of relapsing multiple sclerosis (RMS).NCT02294058·Phoenix, Arizona and 223 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 TrialThe purpose of this study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months, or until it becomes commercially…NCT00648908·Phoenix, Arizona and 31 others

UnknownMeasurement and Training of Dual-Task of Gait in Persons With Multiple SclerosisThe purpose of this study is to determine the utility of a performance measure for the dual-task of gait and considering people with multiple sclerosis have both cognitive and…NCT03536299·Houston, Texas and 1 other

CompletedAn Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to OfatumumabOpen-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or fingolimod due to…NCT04353492·Fullerton, California and 122 others

CompletedAT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MSThe definition of the most 'at-risk' population within highly susceptible groups would provide an opportunity for preemptive therapeutics.NCT00617383·Houston, Texas

Active not recruitingDetermining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMSThe DELIVER-MS study seeks to answer the question: Does early treatment with highly effective DMT improve the prognosis for people with MS? This is an area of significant…NCT03535298·Aurora, Colorado and 29 others

CompletedSafety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple SclerosisMultiple Sclerosis (MS) is a disorder of the body's immune system that affects the Central Nervous System (CNS).NCT00053417·Phoenix, Arizona and 24 others

CompletedObservational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)The primary objective of the study is to evaluate the real-world clinical effectiveness, as measured by the proportion of participants relapsed at 12 months, in participants…NCT02776072·Homewood, Alabama and 120 others

CompletedStudy to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple SclerosisThis is a randomized, double-blind study of PIPE-307 or placebo in subjects with relapsing-remitting multiple sclerosis.NCT06083753·Phoenix, Arizona and 20 others

UnknownAlgorithmic-Based Evaluation and Treatment Approach for Robotic Gait TrainingThe purpose of this study is to develop an algorithmic-based evaluation and treatment approach for wearable robotic exoskeleton (WRE) gait training for patients with neurological…NCT03057652·Houston, Texas

UnknownLongitudinal Optic Neuritis Study (LONS)To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis. To determine the natural history of vision in patients who suffer optic neuritis.NCT00000147·Little Rock, Arkansas and 14 others

CompletedA Study of C105 on Cognitive Dysfunction in Persons With Multiple SclerosisThe purpose of this study is to determine the safety and efficacy of C105 in treating the cognitive deficits that can occur due to multiple sclerosis.NCT00529581·Phoenix, Arizona and 29 others

CompletedBG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)The primary objective of this study is to evaluate the long-term safety profile of BG00012 (dimethyl fumarate).NCT00835770·Birmingham, Alabama and 245 others

CompletedPhase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409Primary Objective: To evaluate long-term safety of alemtuzumab. Secondary Objectives: * To evaluate long term efficacy of alemtuzumab.NCT02255656·Cullman, Alabama and 130 others

Active not recruitingA Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) ElevationThis study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their…NCT05090371·Birmingham, Alabama and 42 others

TerminatedThis Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.The purpose of this study is to evaluate whether FTY720 is effective in delaying MS disability progression compared to placebo in patients with PPMS.NCT00731692·Newport Beach, California and 156 others

CompletedPilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS ExacerbationsThis pilot study is designed as a prospective cohort study to determine whether standard subcutaneous (SQ) Highly-Purified (HP) Acthar Gel 14 days is superior to SQ HP Acthar Gel…NCT01888354·Oceanside, California and 1 other

CompletedAutologous T Cell Vaccine (TCV) for Multiple SclerosisThis is a 1 year study to evaluate the efficacy, safety, and tolerability of Tovaxin T cell therapy in subjects with a clinically isolated syndrome (CIS) and relapse-remitting…NCT00245622·Cullman, Alabama and 32 others

Active not recruitingA Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with RRMS aged between 10 and \< 18…NCT05123703·La Jolla, California and 70 others

CompletedStudy to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.This study evaluates the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early in the course of their disease using clinical and…NCT05084638·Chandler, Arizona and 35 others

Page 1 of 6Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia